A Study of LY3841136 in Healthy and Overweight Participants
Status:
Not yet recruiting
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the safety and tolerability of LY3841136 in
healthy and overweight participants. Blood tests will be performed to check how much
LY3841136 gets into the bloodstream and how long it takes the body to eliminate it. This is a
2-part study and may last up to 14 and 28 weeks for each participant and may include 7 and 19
visits in parts A and B, respectively.